Mumbai-based Lupin Pharmaceuticals is India's most reputed pharmaceutical brand, said a report by Bluebytes, a leading media-analytics company on Wednesday.
Sun Pharma is the second most reputed brand while Cipla is at third position. Hyderabad-based Dr Reddy's Laboratories stands at fourth, according to a statemet from Bluebytes.
Eight Hyderabad-based brands have made it to the list.
Aurobindo Pharma occupies 11th position while Natco Pharma stood at 21st place in the list. Suven Life Sciences ranked at 40, Divis Laboratories at 44th, Zenotech Laboratotries at 48th, Indian Immunologicals at 49th and Biological E. ranked 52nd.
Among global brands GSK leads the way followed by Pfizer. Abbott's ranked India's third most reputed among International brands.
There were 41 domestic and 17 international pharmaceutical brands listed in the study by BlueBytes conducted in association with TRA Research (both part of the Comniscient Group) which released 'India's Most Reputed Pharmaceutical Brands 2016'.
This report is the second in the India's most reputed brands series, and the company is set to launch a report each month covering different sectors. The study evaluates brand's brand reputation by analysing media and consumer perceptions.
"India's reputation as the largest producer of generic drugs in the world has become vulnerable in light of the changing patent regime in the country. Reports say that by 2020, India is likely to be among the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size," said Pooja Kaura, Chief Spokesperson for India's Most Reputed Brands.
--IANS
ms/lok/vt
Disclaimer: No Business Standard Journalist was involved in creation of this content
